Exonate launches diabetic macular oedema trial
admin 4th February 2021 Uncategorised 0Study of lead asset is part of a collaboration with Janssen Pharmaceuticals More: Exonate launches diabetic macular oedema trial Source: News
read more
Study of lead asset is part of a collaboration with Janssen Pharmaceuticals More: Exonate launches diabetic macular oedema trial Source: News
read moreProjects will investigate immune checkpoints and contribute to the development of new cancer treatments More: AstraZeneca and UCL to collaborate on two immuno-oncology projects Source: News
read moreCom-Cov study will be the first in the world to evaluate using different vaccines in a two-dose regimen More: UK trial will evaluate safety of mixing different COVID-19 vaccines Source: News
read moreLatest NHS data shows less people are being referred for certain cancers More: Health leaders urge public to have symptoms checked on World Cancer Day Source: News
read moreAmgen cuts ‘several hundred’ U.S. jobs, primarily sales reps, as COVID-19 speeds a shift to digital bbulik Wed, 02/03/2021 – 14:28 More: Amgen cuts 'several hundred' U.S. jobs, primarily sales reps, as COVID-19 speeds a shift to digital Source: fierce
read moreAs GSK enters key transition year, COVID-19 immunization could hurt Shingrix uptake: exec aliu Wed, 02/03/2021 – 11:40 More: As GSK enters key transition year, COVID-19 immunization could hurt Shingrix uptake: exec Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals